PhD Helena Motaln

PhD Helena Motaln
no.: 21397 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • German
  • Reading: Basic
  • Writing: Basic
  • Speaking: Basic
Edit
Research activity

Code Science Field Subfield
1.05.00  Natural sciences and mathematics  Biochemistry and molecular biology   
3.03.00  Medical sciences  Neurobiology   
Keywords
Genetics of growth, 'high growth' mutation in mice, gene identification, exon trapping, comparative mapping
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
215.18
A''
45.34
A'
86.7
A1/2
182.91
CI10
1,164
CImax
102
h10
22
A1
0.78
A3
0
Data for the last 5 years (citations for the last 10 years) on August 22, 2026; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 45  1,524  1,304  28.98 
Scopus 50  1,711  1,454  29.08 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Jožef Stefan Institute  Odsek za biotehnologijo (Slovene) 
Research projects Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. J1-70029  Modulation of lipid droplet metabolism to overcome metabolic deficiency in neurodegeneration (DROPmode)   3/1/2026 - 2/28/2029  PhD Eva Jarc Jovičić   2,692 
2. J4-70159  TheraPIK3 – Targeted Dual Therapy for PIK3CA-Mutated Breast Cancer Using siRNA and Biomimetic Delivery Systems   3/1/2026 - 2/28/2029  PhD Nina Kostevšek   2,271 
3. GC-0005  Bridging oligonucleotide-based therapeutic upregulation of translation (BOOST)   7/1/2025 - 6/30/2028  PhD Roman Jerala   8,071 
4. J3-60067  Cathepsin Targeted Immunotherapy for Pancreatic Cancer Treatment -CATIMMPACT   1/1/2025 - 12/31/2027  PhD Milica Perišić Nanut   2,380 
5. J3-60057  Dysregulated glycosylation in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia   1/1/2025 - 12/31/2027  PhD Boris Rogelj   911 
6. J2-60047  Magnetic micro-structuring of the Mg alloy surfaces for improved endothelialization and retained degradability of vascular stent materials   1/1/2025 - 12/31/2027  PhD Slavko Kralj   3,826 
7. J7-60125  Non-animal neuro-muscular model to study neurogenic regulation of ion transport and endocrine function of skeletal muscle in vitro (NeuroMyo)   1/1/2025 - 12/31/2027  PhD Sergej Pirkmajer   1,480 
8. J1-50026  A new class of alanine-rich motifs that mediate liquid-liquid phase separation in RNA-binding proteins   10/1/2023 - 9/30/2026  PhD San Hadži   1,110 
9. J7-4639  Antibacterial alloys: development by additive 3D manufacturing, characterization and clinical applications   10/1/2022 - 9/30/2026  PhD Ingrid Milošev   5,759 
10. BI-FR/25-26-PROTEUS-004  The role of FUS protein in neurogenesis   1/1/2025 - 12/31/2025  PhD Helena Motaln   230 
11. L7-4567  Plasma VUV and UV radiation – a method for successful deactivation of Aflatoxins   10/1/2022 - 9/30/2025  PhD Nina Recek   2,252 
12. J3-4503  Translational irregularities underlying C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia   10/1/2022 - 9/30/2025  PhD Boris Rogelj   1,972 
13. J7-3153  Molecular mechanisms of specificity in regulation of secretion and action of muscle-derived cytokines   10/1/2021 - 9/30/2024  PhD Sergej Pirkmajer   4,387 
14. J3-3065  Targeting protein phase separation and aggregation in neurodegenerative TDP-43 proteinopathies   10/1/2021 - 9/30/2024  PhD Boris Rogelj   1,789 
15. N3-0141  Nuclear Transport defects in frontotemporal dementia   3/1/2020 - 2/28/2023  PhD Boris Rogelj   656 
16. L4-9325  Development of new, environment-friendly approaches for plant and human virus inactivation in waters   7/1/2018 - 6/30/2022  PhD Maja Ravnikar   7,398 
17. J7-9399  Phase transitions in systems of nucleotide repeat expansions associated with neurodegenerative diseases   7/1/2018 - 6/30/2022  PhD Irena Drevenšek Olenik   4,112 
18. J3-9262  Advanced surface finishing technologies for antibacterial properties of patient specific 3D printed implantable materials   7/1/2018 - 6/30/2021  PhD Ita Junkar   5,603 
19. J3-9263  Pathogenic role of paraspeckle-like nuclear bodies in neurodegenerative diseases ALS and FTD   7/1/2018 - 6/30/2021  PhD Boris Rogelj   2,201 
20. J3-8201  Okvare jedrnega transporta pri nevrodegenerativnih boleznih (Slovene)   5/1/2017 - 4/30/2020  PhD Boris Rogelj   2,593 
21. J1-7119  EpCAM Biology at Structural Level as a Foundation for Efficient Tumor Targeting   1/1/2016 - 12/31/2018  PhD Brigita Lenarčič   4,441 
22. J1-6730  Razvoj novih celičnih linij človeških jeter za raziskave genotoksičnosti in karcinogenosti: novo upanje za človekovo zdravje in zaščito laboratorijskih živali (Slovene)   11/1/2014 - 10/31/2017  PhD Metka Filipič   4,670 
23. J2-5478  Razvoj in aplikacije novih metod semantičnega rudarjenja podatkov v znanostih o življenju (Slovene)   8/1/2013 - 7/31/2016  PhD Nada Lavrač   3,516 
24. J1-4247  Dvojna narava matičnih celic v raku in njihova uporaba v zdravljenju (Slovene)   7/1/2011 - 6/30/2014  PhD Tamara Lah Turnšek   5,723 
25. L3-4328  Hipoksična neaktivnost: implikacije za odpoved srca, pljučno insuficienco in prekomerno težo (Slovene)   7/1/2011 - 6/30/2014  PhD Igor Mekjavić   6,471 
26. J1-2095  Apoptoza tumorskih celic kot tarča kemoterapevtikov (Slovene)   5/1/2009 - 4/30/2012  PhD Tamara Lah Turnšek   2,047 
27. L1-0055  Use of mesenchymal stem cells to target gliomas: Risk assessment and evaluation of umbilical cord blood-derived mesenchymal stem cells as new cellular vectors for therapy.   2/1/2008 - 1/30/2011  PhD Irena Zajc   2,234 
28. Z4-7329  Development of transgenic mouse models to study the function of Cyp51 and Raidd genes   9/1/2005 - 8/31/2007  PhD Simon Horvat   834 
29. J4-6115  Molecular bases of interactions between hosts and pathogenic microorganisms   2/1/2004 - 1/30/2007  PhD Simon Horvat   5,496 
30. V4-0980  Populacijska dinamika divjega prašiča (Sus scrofa), vpliv notranjih in zunanjih dejavnikov nanjo in prognoza razvojnih trendov v Sloveniji (Slovene)   9/1/2004 - 11/30/2006  PhD Miha Adamič   4,574 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head of the Last Period
1. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Anja Pišlar   5,952 
2. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2015 - 12/31/2018 PhD Tamara Lah Turnšek   3,663 
3. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,599 
4. P1-0245  Ekotoksiologija, toksikološka genomika in karcinogeneza (Slovene)   1/1/2009 - 12/31/2014 PhD Tamara Lah Turnšek   3,704 
5. P4-0220  Comparative genomics and genomic biodiversity   1/1/2004 - 12/31/2008 PhD Peter Dovč   4,831 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite